US 12378557
Treatment of sepsis with PCSK9 and LDLR modulators
granted A61PA61P31/00
Quick answer
US patent 12378557 (Treatment of sepsis with PCSK9 and LDLR modulators) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P31/00